Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Entera Bio Ltd (ENTX)

Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Entera Bio Ltd KIRYAT HADASSAH MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 ISR

www.enterabio.com P: 972-2532-7151

Description:

Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.

Key Statistics

Overview:

Market Capitalization, $K 73,717
Enterprise Value, $K 62,697
Shares Outstanding, K 35,785
Annual Sales, $ 0 K
Annual Net Income, $ -8,890 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,020 K
EBIT, $ -8,740 K
EBITDA, $ -8,680 K
60-Month Beta 1.59
% of Insider Shareholders 10.90%
% of Institutional Shareholders 14.11%
Float, K 31,884
% Float 89.10%
Short Volume Ratio 0.39

Growth:

1-Year Return 129.27%
3-Year Return -66.77%
5-Year Return -37.20%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 76.34%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 05/10/24
Next Earnings Date 08/09/24
Earnings Per Share ttm -0.28
EPS Growth vs. Prev Qtr 28.57%
EPS Growth vs. Prev Year 37.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ENTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -103.40%
Return-on-Assets % -85.01%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 8.26
Book Value/Share 0.25
Interest Coverage -1.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar